6-heptyne-2,5-diamine has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bowlin, TL; Davis, GF; Hoeper, BJ; Rosenberger, AL; Sunkara, PS | 1 |
1 other study(ies) available for 6-heptyne-2,5-diamine and B16 Melanoma
Article | Year |
---|---|
Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
Topics: Alkynes; Animals; Antineoplastic Agents; Cell Line; Cytotoxicity, Immunologic; Diamines; Eflornithine; Interferon-gamma; Killer Cells, Natural; Kinetics; Macrophages; Melanoma, Experimental; Mice; Ornithine Decarboxylase Inhibitors; Polyamines; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1990 |